<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Arial,Italic" color="#000000"/>
	<fontspec id="font1" size="9" family="Arial" color="#000000"/>
	<fontspec id="font2" size="9" family="Arial,Bold" color="#000000"/>
	<fontspec id="font3" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font4" size="11" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font5" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font6" size="10" family="Symbol" color="#000000"/>
<text top="41" left="55" width="157" height="10" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title">Clinical and Molecular Allergy 2005, 3 :6<i>Clinical and Molecular Allergy</i></text>
<text top="41" left="343" width="211" height="10" font="font1" id="p1_t2" reading_order_no="1" segment_no="1" tag_type="text">http://www.clinicalmolecularallergy.com/content/3/1/6</text>
<text top="756" left="503" width="51" height="10" font="font1" id="p1_t3" reading_order_no="105" segment_no="9" tag_type="text">Page 2 of 12<b>3</b></text>
<text top="769" left="432" width="122" height="8" font="font3" id="p1_t4" reading_order_no="106" segment_no="10" tag_type="text">(page number not for citation purposes)</text>
<text top="87" left="55" width="60" height="10" font="font4" id="p1_t5" reading_order_no="2" segment_no="2" tag_type="title">Background</text>
<text top="98" left="55" width="241" height="9" font="font5" id="p1_t6" reading_order_no="3" segment_no="4" tag_type="text">Chronic inflammation and airway smooth muscle dys-</text>
<text top="110" left="55" width="241" height="9" font="font5" id="p1_t7" reading_order_no="4" segment_no="4" tag_type="text">function are consistent features of asthma responsible for<i>(page number not for citation purposes)</i></text>
<text top="122" left="55" width="241" height="9" font="font5" id="p1_t8" reading_order_no="5" segment_no="4" tag_type="text">disease progression and airway remodeling [1]. The<b>Background</b></text>
<text top="134" left="55" width="241" height="9" font="font5" id="p1_t9" reading_order_no="6" segment_no="4" tag_type="text">increase in bronchial smooth muscle, both hypertrophy</text>
<text top="145" left="55" width="241" height="9" font="font5" id="p1_t10" reading_order_no="7" segment_no="4" tag_type="text">[2] and hyperplasia [3], plays a critical role in the develop-</text>
<text top="157" left="55" width="241" height="9" font="font5" id="p1_t11" reading_order_no="8" segment_no="4" tag_type="text">ment of airway hyperreactivity (AHR), the hallmark of<a href="">[1]. </a>The</text>
<text top="169" left="55" width="241" height="9" font="font5" id="p1_t12" reading_order_no="9" segment_no="4" tag_type="text">asthma. Airway smooth muscle cells (ASMC) may also</text>
<text top="181" left="55" width="241" height="9" font="font5" id="p1_t13" reading_order_no="10" segment_no="4" tag_type="text">play a secretory or immunomodulatory role by producing<a href="">2</a>] and hy<a href="">perplasia [3], plays a critical role in </a>the develop-</text>
<text top="192" left="55" width="241" height="9" font="font5" id="p1_t14" reading_order_no="11" segment_no="4" tag_type="text">pro-inflammatory cytokines, chemokines, polypeptide</text>
<text top="204" left="55" width="241" height="9" font="font5" id="p1_t15" reading_order_no="12" segment_no="4" tag_type="text">growth factors, extracellular matrix proteins, cell adhesion</text>
<text top="216" left="55" width="241" height="9" font="font5" id="p1_t16" reading_order_no="13" segment_no="4" tag_type="text">receptors, and co-stimulatory molecules, which perpetu-</text>
<text top="228" left="55" width="241" height="9" font="font5" id="p1_t17" reading_order_no="14" segment_no="4" tag_type="text">ate submucosal inflammation [4,5]. These mediators may</text>
<text top="239" left="55" width="241" height="9" font="font5" id="p1_t18" reading_order_no="15" segment_no="4" tag_type="text">act on the ASM itself in an autocrine manner as well to fur-</text>
<text top="251" left="55" width="241" height="9" font="font5" id="p1_t19" reading_order_no="16" segment_no="4" tag_type="text">ther contribute to the asthma phenotype [6]. Therefore,</text>
<text top="263" left="55" width="241" height="9" font="font5" id="p1_t20" reading_order_no="17" segment_no="4" tag_type="text">smooth muscle itself may be capable of initiating and<a href="">[4,5]. These mediator</a>s may</text>
<text top="275" left="55" width="241" height="9" font="font5" id="p1_t21" reading_order_no="18" segment_no="4" tag_type="text">maintaining airway inflammation. Also, ASMC have been</text>
<text top="286" left="55" width="241" height="9" font="font5" id="p1_t22" reading_order_no="19" segment_no="4" tag_type="text">shown to undergo cell migration, which could contribute<a href="">otype [6]. The</a>refore,</text>
<text top="298" left="55" width="241" height="9" font="font5" id="p1_t23" reading_order_no="20" segment_no="4" tag_type="text">to airway remodeling [7]. Thus, regulation of airway</text>
<text top="310" left="55" width="241" height="9" font="font5" id="p1_t24" reading_order_no="21" segment_no="4" tag_type="text">smooth muscle hypertrophy and migration may be a new</text>
<text top="322" left="55" width="151" height="9" font="font5" id="p1_t25" reading_order_no="22" segment_no="4" tag_type="text">target for treatment of asthma [7,8].</text>
<text top="345" left="55" width="241" height="9" font="font5" id="p1_t26" reading_order_no="23" segment_no="6" tag_type="text">It is well known that IgE plays a critical role in the patho-<a href="">odeling [7]. Thus, regulation</a> of airway</text>
<text top="357" left="55" width="241" height="9" font="font5" id="p1_t27" reading_order_no="24" segment_no="6" tag_type="text">genesis of asthma in the early and late phases by interact-</text>
<text top="369" left="55" width="241" height="9" font="font5" id="p1_t28" reading_order_no="25" segment_no="6" tag_type="text">ing with its two receptors, the high affinity receptor<a href=""> [7,8].</a></text>
<text top="377" left="55" width="241" height="13" font="font5" id="p1_t29" reading_order_no="26" segment_no="6" tag_type="text">(Fc ε RI) and the low affinity receptor (Fc ε RII) [9]. IgE plays</text>
<text top="392" left="55" width="241" height="9" font="font5" id="p1_t30" reading_order_no="27" segment_no="6" tag_type="text">a key role in bronchial hyperresponsiveness and smooth</text>
<text top="404" left="55" width="241" height="9" font="font5" id="p1_t31" reading_order_no="28" segment_no="6" tag_type="text">muscle hyperreactivity [8]. Crosslinking of the high affin-</text>
<text top="413" left="55" width="241" height="13" font="font5" id="p1_t32" reading_order_no="29" segment_no="6" tag_type="text">ity IgE receptor (Fc ε RI) on mast cells leads to cellular</text>
<text top="427" left="55" width="241" height="9" font="font5" id="p1_t33" reading_order_no="30" segment_no="6" tag_type="text">degranulation and the release of various proinflammatory</text>
<text top="439" left="55" width="241" height="9" font="font5" id="p1_t34" reading_order_no="31" segment_no="6" tag_type="text">mediators and cytokines contributing to bronchoconstric-</text>
<text top="448" left="55" width="242" height="13" font="font5" id="p1_t35" reading_order_no="32" segment_no="6" tag_type="text">tion. The low affinity IgE receptor (CD23) (Fc ε RII) has</text>
<text top="463" left="55" width="241" height="9" font="font5" id="p1_t36" reading_order_no="33" segment_no="6" tag_type="text">been identified on B cells, monocytes, follicular dendritic<a href="">RII) [9]. IgE plays</a></text>
<text top="474" left="55" width="241" height="9" font="font5" id="p1_t37" reading_order_no="34" segment_no="6" tag_type="text">cells, Langerhan's cells, eosinophils, and platelets [10].</text>
<text top="486" left="55" width="241" height="9" font="font5" id="p1_t38" reading_order_no="35" segment_no="6" tag_type="text">Upregulation of the CD23 receptor is thought to increase<a href="">tivity [8]. Cross</a>linking of the high affin-</text>
<text top="498" left="55" width="241" height="9" font="font5" id="p1_t39" reading_order_no="36" segment_no="6" tag_type="text">allergic responses in the bronchial mucosa through the</text>
<text top="510" left="55" width="241" height="9" font="font5" id="p1_t40" reading_order_no="37" segment_no="6" tag_type="text">enhancement of antigen uptake and presentation [8]. The</text>
<text top="521" left="55" width="241" height="9" font="font5" id="p1_t41" reading_order_no="38" segment_no="6" tag_type="text">receptor has two isoforms that differ only in their cyto-</text>
<text top="533" left="55" width="241" height="9" font="font5" id="p1_t42" reading_order_no="39" segment_no="6" tag_type="text">plasmic domains [11]. CD23a is constitutively expressed</text>
<text top="545" left="55" width="241" height="9" font="font5" id="p1_t43" reading_order_no="40" segment_no="6" tag_type="text">on B cells and is associated with endocytosis of IgE coated</text>
<text top="557" left="55" width="241" height="9" font="font5" id="p1_t44" reading_order_no="41" segment_no="6" tag_type="text">particles, and CD23b is induced by IL-4 and is also found</text>
<text top="568" left="55" width="241" height="9" font="font5" id="p1_t45" reading_order_no="42" segment_no="6" tag_type="text">on non- B cells such as T cells, Langerhan's cells, mono-</text>
<text top="580" left="55" width="241" height="9" font="font5" id="p1_t46" reading_order_no="43" segment_no="6" tag_type="text">cytes, macrophages, platelets, and eosinophils [12,13]. IL-</text>
<text top="592" left="55" width="241" height="9" font="font5" id="p1_t47" reading_order_no="44" segment_no="6" tag_type="text">4 causes CD23 induction on B cells through CD40 [12].</text>
<text top="604" left="55" width="241" height="9" font="font5" id="p1_t48" reading_order_no="45" segment_no="6" tag_type="text">CD23b mediates phagocytosis of soluble IgE complexes.<a href="">[10].</a></text>
<text top="615" left="55" width="241" height="9" font="font5" id="p1_t49" reading_order_no="46" segment_no="6" tag_type="text">An autocatalytic process involving cleavage of membrane</text>
<text top="627" left="55" width="241" height="9" font="font5" id="p1_t50" reading_order_no="47" segment_no="6" tag_type="text">bound CD23 by a matrix metalloprotease yields a series of</text>
<text top="639" left="55" width="241" height="9" font="font5" id="p1_t51" reading_order_no="48" segment_no="6" tag_type="text">soluble elements (sCD23) which increase IgE production<a href=""> [8]. The</a></text>
<text top="651" left="55" width="171" height="9" font="font5" id="p1_t52" reading_order_no="49" segment_no="6" tag_type="text">via the CD21 receptor on B cells [13,14].</text>
<text top="674" left="55" width="241" height="9" font="font5" id="p1_t53" reading_order_no="50" segment_no="8" tag_type="text">The CD23 receptor has been shown to be upregulated on<a href="">ains [11]. CD</a>23a is constitutively expressed</text>
<text top="686" left="55" width="241" height="9" font="font5" id="p1_t54" reading_order_no="51" segment_no="8" tag_type="text">monocytes and alveolar macrophages in a T helper cell</text>
<text top="698" left="55" width="241" height="9" font="font5" id="p1_t55" reading_order_no="52" segment_no="8" tag_type="text">type 2 (TH2) environment and may contribute to chronic</text>
<text top="709" left="55" width="241" height="9" font="font5" id="p1_t56" reading_order_no="53" segment_no="8" tag_type="text">inflammation in asthma through this mechanism [15]. It</text>
<text top="721" left="55" width="241" height="9" font="font5" id="p1_t57" reading_order_no="54" segment_no="8" tag_type="text">has been shown that IL-4 and GM-CSF induce CD23<a href="">[12,13]. IL-</a></text>
<text top="87" left="313" width="241" height="9" font="font5" id="p1_t58" reading_order_no="55" segment_no="3" tag_type="text">expression on monocytes, and GM-CSF primes mono-<a href="">[12].</a></text>
<text top="98" left="313" width="241" height="9" font="font5" id="p1_t59" reading_order_no="56" segment_no="3" tag_type="text">cytes for cellular activation and secretion of IL-1 upon</text>
<text top="110" left="313" width="241" height="9" font="font5" id="p1_t60" reading_order_no="57" segment_no="3" tag_type="text">subsequent exposure to IgE-containing immune com-</text>
<text top="122" left="313" width="241" height="9" font="font5" id="p1_t61" reading_order_no="58" segment_no="3" tag_type="text">plexes [8]. CD23 is also involved in antigen presentation</text>
<text top="134" left="313" width="241" height="9" font="font5" id="p1_t62" reading_order_no="59" segment_no="3" tag_type="text">to B cells as well as cellular interactions between B and T</text>
<text top="145" left="313" width="41" height="9" font="font5" id="p1_t63" reading_order_no="60" segment_no="3" tag_type="text">cells [12].<a href=""> cells [13</a>,<a href="">14].</a></text>
<text top="169" left="313" width="241" height="9" font="font5" id="p1_t64" reading_order_no="61" segment_no="5" tag_type="text">In previous studies, Hakonarson et al. [16] demonstrated</text>
<text top="178" left="313" width="241" height="13" font="font5" id="p1_t65" reading_order_no="62" segment_no="5" tag_type="text">the expression of CD23 (Fc ε RII) messages and a low level</text>
<text top="192" left="313" width="241" height="9" font="font5" id="p1_t66" reading_order_no="63" segment_no="5" tag_type="text">of the protein in airway smooth muscle cells. In two</text>
<text top="204" left="313" width="241" height="9" font="font5" id="p1_t67" reading_order_no="64" segment_no="5" tag_type="text">patients who died of status asthmaticus, CD23 expression<a href="">[15</a>]. It</text>
<text top="216" left="313" width="241" height="9" font="font5" id="p1_t68" reading_order_no="65" segment_no="5" tag_type="text">was also markedly upregulated on ASMC. The CD23</text>
<text top="228" left="313" width="241" height="9" font="font5" id="p1_t69" reading_order_no="66" segment_no="5" tag_type="text">expression was inducible with human atopic sera or IgE</text>
<text top="239" left="313" width="241" height="9" font="font5" id="p1_t70" reading_order_no="67" segment_no="5" tag_type="text">immune complexes in naïve (control) ASMC, and this</text>
<text top="251" left="313" width="241" height="9" font="font5" id="p1_t71" reading_order_no="68" segment_no="5" tag_type="text">upregulation was blocked when pretreated with anti-</text>
<text top="263" left="313" width="241" height="9" font="font5" id="p1_t72" reading_order_no="69" segment_no="5" tag_type="text">CD23 blocking antibody. The authors concluded that IgE<a href="">plexes [8]. </a>CD23 is also involved in antigen presentation</text>
<text top="275" left="313" width="241" height="9" font="font5" id="p1_t73" reading_order_no="70" segment_no="5" tag_type="text">coupled activation of CD23 contributes largely to its</text>
<text top="286" left="313" width="241" height="9" font="font5" id="p1_t74" reading_order_no="71" segment_no="5" tag_type="text">upregulation [5,14]. In a corresponding experiment with<a href="">cells [12].</a></text>
<text top="298" left="313" width="241" height="9" font="font5" id="p1_t75" reading_order_no="72" segment_no="5" tag_type="text">rabbit ASMC subjected to control and atopic serum, they<a href="">16] dem</a>onstrated</text>
<text top="310" left="313" width="241" height="9" font="font5" id="p1_t76" reading_order_no="73" segment_no="5" tag_type="text">were able to demonstrate, through Western blot analysis,</text>
<text top="322" left="313" width="241" height="9" font="font5" id="p1_t77" reading_order_no="74" segment_no="5" tag_type="text">a markedly enhanced expression of CD23 in the ASMC</text>
<text top="333" left="313" width="241" height="9" font="font5" id="p1_t78" reading_order_no="75" segment_no="5" tag_type="text">sensitized with atopic serum or IgE immune complexes.</text>
<text top="345" left="313" width="241" height="9" font="font5" id="p1_t79" reading_order_no="76" segment_no="5" tag_type="text">They were able to achieve significant inhibition of upreg-</text>
<text top="357" left="313" width="241" height="9" font="font5" id="p1_t80" reading_order_no="77" segment_no="5" tag_type="text">ulation by pretreatment with anti-CD23 mAb. They</text>
<text top="369" left="313" width="241" height="9" font="font5" id="p1_t81" reading_order_no="78" segment_no="5" tag_type="text">hypothesized that IgE was responsible for the upregula-</text>
<text top="380" left="313" width="241" height="9" font="font5" id="p1_t82" reading_order_no="79" segment_no="5" tag_type="text">tion of the low affinity IgE receptor [17]. Hakonarson, et</text>
<text top="392" left="313" width="241" height="9" font="font5" id="p1_t83" reading_order_no="80" segment_no="5" tag_type="text">al. have also demonstrated that ASMC in vitro exposed to</text>
<text top="404" left="313" width="241" height="9" font="font5" id="p1_t84" reading_order_no="81" segment_no="5" tag_type="text">human atopic sera results in an initial increase in TH2</text>
<text top="416" left="313" width="241" height="9" font="font5" id="p1_t85" reading_order_no="82" segment_no="5" tag_type="text">cytokines including IL-5 and GM-CSF followed hours</text>
<text top="427" left="313" width="241" height="9" font="font5" id="p1_t86" reading_order_no="83" segment_no="5" tag_type="text">later by production of IL-1 and TH1 cytokines [18,19].</text>
<text top="439" left="313" width="241" height="9" font="font5" id="p1_t87" reading_order_no="84" segment_no="5" tag_type="text">Recently, phase I trials have been completed on IDEC-<a href="">ation [5,14]. </a>In a corresponding experiment with</text>
<text top="451" left="313" width="241" height="9" font="font5" id="p1_t88" reading_order_no="85" segment_no="5" tag_type="text">152, an IgG1 anti-CD23 antibody, for patients with mild</text>
<text top="463" left="313" width="241" height="9" font="font5" id="p1_t89" reading_order_no="86" segment_no="5" tag_type="text">to moderate persistent asthma. The drug was well toler-</text>
<text top="474" left="313" width="241" height="9" font="font5" id="p1_t90" reading_order_no="87" segment_no="5" tag_type="text">ated by participants, and a dose-dependent decrease in</text>
<text top="486" left="313" width="147" height="9" font="font5" id="p1_t91" reading_order_no="88" segment_no="5" tag_type="text">mean IgE values was reported [20].</text>
<text top="510" left="313" width="241" height="9" font="font5" id="p1_t92" reading_order_no="89" segment_no="7" tag_type="text">T helper cell type 2 (TH2) mediated inflammatory</text>
<text top="521" left="313" width="241" height="9" font="font5" id="p1_t93" reading_order_no="90" segment_no="7" tag_type="text">cytokines, such as IL-4, IL-13, and IL-5, as well as other</text>
<text top="533" left="313" width="241" height="9" font="font5" id="p1_t94" reading_order_no="91" segment_no="7" tag_type="text">enzymes and chemokines are active in the asthmatic</text>
<text top="545" left="313" width="241" height="9" font="font5" id="p1_t95" reading_order_no="92" segment_no="7" tag_type="text">patient. GM-CSF has been shown to be involved in<a href=""> [17]. Hak</a>onarson, et</text>
<text top="557" left="313" width="241" height="9" font="font5" id="p1_t96" reading_order_no="93" segment_no="7" tag_type="text">asthma pathogenesis and in vivo can induce TH2 differen-</text>
<text top="568" left="313" width="241" height="9" font="font5" id="p1_t97" reading_order_no="94" segment_no="7" tag_type="text">tiation independent of IL-4 [21]. Tryptase and prostagla-</text>
<text top="580" left="313" width="241" height="9" font="font5" id="p1_t98" reading_order_no="95" segment_no="7" tag_type="text">din D2 (PGD2) were chosen as major mast cell mediators,</text>
<text top="592" left="313" width="241" height="9" font="font5" id="p1_t99" reading_order_no="96" segment_no="7" tag_type="text">and more recently the PGD2 receptor gene (PTGDR) has<a href="">s [18,19</a>].</text>
<text top="604" left="313" width="241" height="9" font="font5" id="p1_t100" reading_order_no="97" segment_no="7" tag_type="text">been shown to be an asthma susceptibility gene [22-24].</text>
<text top="615" left="313" width="241" height="9" font="font5" id="p1_t101" reading_order_no="98" segment_no="7" tag_type="text">It is possible that many factors are responsible for the</text>
<text top="627" left="313" width="241" height="9" font="font5" id="p1_t102" reading_order_no="99" segment_no="7" tag_type="text">upregulation of the low affinity IgE receptor in addition to</text>
<text top="639" left="313" width="241" height="9" font="font5" id="p1_t103" reading_order_no="100" segment_no="7" tag_type="text">and independent of IgE. The purpose of this study was to</text>
<text top="651" left="313" width="241" height="9" font="font5" id="p1_t104" reading_order_no="101" segment_no="7" tag_type="text">identify specific mediators released in the asthmatic<a href="">d [20].</a></text>
<text top="662" left="313" width="241" height="9" font="font5" id="p1_t105" reading_order_no="102" segment_no="7" tag_type="text">patient that are responsible for the upregulation of CD23</text>
<text top="674" left="313" width="241" height="9" font="font5" id="p1_t106" reading_order_no="103" segment_no="7" tag_type="text">on human airway smooth muscle cells independent of</text>
<text top="686" left="313" width="16" height="9" font="font5" id="p1_t107" reading_order_no="104" segment_no="7" tag_type="text">IgE.</text>
</page>
</pdf2xml>
